MedTrace Logo

Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder

NCT03716869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12909

Last updated 2024-01-11

Study results available
· View outcomes & findings →

Summary

The primary goal of the proposed study is to compare the effectiveness of universal school based screening for adolescent major depressive disorder to the current school process of targeted screening based on concerning behavior.

Conditions

Interventions

OTHER

Universal Screening Arm

Students with PHQ-9 score \>10, corresponding to a positive MDD screen, will proceed through the same SAP triage process as students referred by traditional means. SAP triage will determine MDD identification. As SAP triage is not diagnostic, MDD identification is based on SAP recommendations for MDD related school or community services. Treatment engagement will be tracked per current SAP processes. To immediately identify and address suicidal intent, the survey will flag a positive response to PHQ-9 question 9 in real time. A suicidal student would proceed directly to management through the school crisis plan. Students in the intervention arm will also be tracked for behavior concerning for MDD at any point in the school year prompting SAP triage referral.

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Deepa Sekhar, MD · Penn State College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-06
Primary Completion
2020-11-20
Completion
2021-02-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03716869 on ClinicalTrials.gov